Market Overview:
The global methicillin-resistant Staphylococcus aureus (MRSA) testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of MRSA infections, rising demand for rapid and accurate diagnosis, and technological advancements in MRSA testing methods. The global MRSA testing market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into blood testing, immunodiagnostics, and others. Blood testing accounted for the largest share of the global MRSA Testing Market in 2017 owing to its ability to detect both invasive as well as noninvasive strains of MRSA bacteria.
Product Definition:
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that's resistant to many antibiotics, including methicillin. MRSA can cause skin infections, pneumonia, and other serious illnesses. Laboratory testing is used to identify MRSA and determine its antibiotic susceptibility. Testing is important for guiding treatment decisions and preventing the spread of MRSA infections.
Blood Testing:
Blood testing is used to detect the presence of microorganisms in blood. It includes analysis of different types of blood samples such as serum, plasma, and whole blood for bacteria and certain viruses like HBV & HCV. Blood tests are widely used for diagnosis of diseases caused by germs such as streptococcus pneumoniae ( pneumococcal disease), Haemophilus influenzae (H influenzae infection) and meningococcal disease.
Immunodiagnostics:
Immunodiagnostics is the branch of clinical laboratory science that deals with the detection and identification of disease-causing microorganisms by using antibodies as biological markers. Immunodiagnostic tests are used to detect diseases in patients, which cannot be diagnosed through physical examination. These tests also help in monitoring the effectiveness of treatment given to a patient.
Application Insights:
The hospital application segment led the market and accounted for more than 70% share of the global revenue in 2017. The growth is attributed to factors such as increasing number of hospitals, rise in healthcare spending, and high prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) infections. According to data published by CDC, around 2 million people were diagnosed with MRSA infection in U.S., which was estimated to have resulted in over 21 thousand deaths during the year 2013-2015.
Clinical trials are being conducted at various institutions for developing new diagnostic techniques that can be used not only for identifying patients infected with MRSA but also help detect it earlier so that appropriate treatment can be started before its spread becomes widespread among population groups or other susceptible individuals get affected later on. This will help curb further spread of this bacteria and reduce healthcare associated costs & mortality rates globally over the forecast period.
Regional Analysis:
North America accounted for the largest share of over 40.0% in 2017, owing to the high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile infections in this region. The U.S., which is one of the most developed countries globally, continues to be a major market for healthcare IT companies developing innovative solutions for disease management and diagnosis.
Asia Pacific is expected to register significant growth during the forecast period due to increasing government initiatives towards early diagnosis coupled with rising awareness about antimicrobial resistance among patients & general public as well as healthcare professionals.
Europe also contributed significantly toward revenue generation in 2017 owing to high incidence rates of multi-drug resistant tuberculosis coupled with an aging population that requires increased care at hospitals.
Growth Factors:
- Increasing incidence of MRSA infections: The incidence of MRSA infections is increasing at a rapid pace across the globe. This is primarily attributed to the growing prevalence of antibiotic resistance among various strains of bacteria. As a result, there is an increased demand for methicillin-resistant Staphylococcus aureus (MRSA) testing services to accurately diagnose and treat such infections.
- Rising awareness about MRSA: There is an increasing awareness among people about methicillin-resistant Staphylococcus aureus (MRSA) and its associated risks. This has led to an increase in the demand for MRSA testing services, as patients are now seeking early diagnosis and treatment for such infections.
- Growing number of outbreaks due to MRSA: The number of outbreaks caused by methicillin-resistant Staphylococcus aureus (MRSA) is on the rise globally, which has resulted in an increased demand for diagnostic tests for this pathogen strain. Hospitals and other healthcare facilities are increasingly adopting stringent infection control measures to prevent the spread of these pathogens amongst patients and staff members alike .This is expected to fuel growth in the global market for methicillin-resistant Staphylococcus Aureus Testing over the next few years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Methicillin-Resistant Staphylococcus Aureus Testing Market Research Report
By Type
Blood Testing, Immunodiagnostics, Others
By Application
Hospital, Clinic, Diagnostic Center, Others
By Companies
Roche, BD, Bio-Rad, Biomerieux, Abbott, Danaher, Hain Lifescience, Abacus Diagnostica, Eurofins, Puritan Medical, Arlington Scientific, Luminex
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Methicillin-Resistant Staphylococcus Aureus Testing Market Report Segments:
The global Methicillin-Resistant Staphylococcus Aureus Testing market is segmented on the basis of:
Types
Blood Testing, Immunodiagnostics, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- BD
- Bio-Rad
- Biomerieux
- Abbott
- Danaher
- Hain Lifescience
- Abacus Diagnostica
- Eurofins
- Puritan Medical
- Arlington Scientific
- Luminex
Highlights of The Methicillin-Resistant Staphylococcus Aureus Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Testing
- Immunodiagnostics
- Others
- By Application:
- Hospital
- Clinic
- Diagnostic Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Methicillin-Resistant Staphylococcus Aureus Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Methicillin-resistant Staphylococcus Aureus (MRSA) testing is a procedure used to determine if a patient has MRSA. This test is used to identify the presence of MRSA in the body and can help guide treatment.
Some of the major players in the methicillin-resistant staphylococcus aureus testing market are Roche, BD, Bio-Rad, Biomerieux, Abbott, Danaher, Hain Lifescience, Abacus Diagnostica, Eurofins, Puritan Medical, Arlington Scientific, Luminex.
The methicillin-resistant staphylococcus aureus testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Methicillin-Resistant Staphylococcus Aureus Testing Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Methicillin-Resistant Staphylococcus Aureus Testing Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Methicillin-Resistant Staphylococcus Aureus Testing Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Size & Forecast, 2018-2028 4.5.1 Methicillin-Resistant Staphylococcus Aureus Testing Market Size and Y-o-Y Growth 4.5.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Absolute $ Opportunity
Chapter 5 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
5.2.1 Blood Testing
5.2.2 Immunodiagnostics
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Center
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Methicillin-Resistant Staphylococcus Aureus Testing Analysis and Forecast
9.1 Introduction
9.2 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
9.6.1 Blood Testing
9.6.2 Immunodiagnostics
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Center
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Methicillin-Resistant Staphylococcus Aureus Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
10.6.1 Blood Testing
10.6.2 Immunodiagnostics
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Center
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
11.6.1 Blood Testing
11.6.2 Immunodiagnostics
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Center
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Methicillin-Resistant Staphylococcus Aureus Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
12.6.1 Blood Testing
12.6.2 Immunodiagnostics
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Center
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Methicillin-Resistant Staphylococcus Aureus Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Type
13.6.1 Blood Testing
13.6.2 Immunodiagnostics
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Methicillin-Resistant Staphylococcus Aureus Testing Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Center
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Methicillin-Resistant Staphylococcus Aureus Testing Market: Competitive Dashboard
14.2 Global Methicillin-Resistant Staphylococcus Aureus Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 BD
14.3.3 Bio-Rad
14.3.4 Biomerieux
14.3.5 Abbott
14.3.6 Danaher
14.3.7 Hain Lifescience
14.3.8 Abacus Diagnostica
14.3.9 Eurofins
14.3.10 Puritan Medical
14.3.11 Arlington Scientific
14.3.12 Luminex